Zolmitriptan attenuates hepatocellular carcinoma via activation of caspase mediated apoptosis-Reference-Cited by-同舟云学术

Zolmitriptan attenuates hepatocellular carcinoma via activation of caspase mediated apoptosis

Published:2019-08 Issue: Volume:308 Page:120-129
ISSN:0009-2797
Container-title:Chemico-Biological Interactions
language:en
Short-container-title:Chemico-Biological Interactions

Author:

Maurya Vimal,Kumar Pranesh,Chakraborti Sreemoyee,Singh Ashok K.,Bhadauria Archana S.,Kumar Umesh,Kumar Dinesh^ORCID,Pramanik Arnab,Saha Biswajit,Kumar R Venkatesh,Gosipatala Sunil Babu^ORCID,Bhattachariya Bolay,Maity Biswanath,Saha Sudipta

Funder

UGC, India

DST, India

DST India

ICMR, India

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference46 articles.

1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;Ferlay;Int. J. Cancer,2010

2. Management of hepatocellular carcinoma: an update;Bruix;Hepatology,2011

3. Discovery and development of sorafenib: a multikinase inhibitor for treating cancer;Wilhelm;Nat. Rev. Drug Discov.,2006

4. Treatment of advanced hepatocellular carcinoma after failure of sorafenib treatment: subsequent or additional treatment interventions contribute to prolonged survival post progression;Kondo;Gastroenterol. Res. Pract.,2017

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical evaluation of dalbergin loaded PLGA-galactose-modified nanoparticles against hepatocellular carcinoma via inhibition of the AKT/NF-κB signaling pathway;International Immunopharmacology;2024-10

2. Regulator-carrying dual-responsive integrated AuNP composite fluorescence probe for in situ real time monitoring apoptosis progression;Talanta;2024-03

3. Vinpocetine mitigates DMH-induce pre-neoplastic colon damage in rats through inhibition of pro-inflammatory cytokines;International Immunopharmacology;2023-06

4. Regulator-Carrying Dual-Responsive Integrated AuNP Composite Fluorescence Probe for in Situ Real Time Monitoring Apoptosis Progression;2023

5. Assessment of hyaluronic acid-modified imatinib mesylate cubosomes through CD44 targeted drug delivery in NDEA-induced hepatic carcinoma;International Journal of Pharmaceutics;2022-06